NCT07513220 The Effectiveness and Acceptability of Formal Versus Informal Mindful Self-Compassion for Adolescents
| NCT ID | NCT07513220 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cambridge Health Alliance |
| Condition | Coping |
| Study Type | INTERVENTIONAL |
| Enrollment | 135 participants |
| Start Date | 2026-04-13 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 135 participants in total. It began in 2026-04-13 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if two types of mindful self-compassion programs work to improve coping in adolescents. The investigators will also learn about adolescents' liking of, and the other potential mental health and academic benefits of, these programs. The main questions this clinical trial aims to answer are: * Do two types of mindful self-compassion programs improve coping in adolescents? * Do two types of mindful self-compassion programs improve mental health (e.g., stress, anxiety, depression) and academic outcomes (e.g., academic engagement) in adolescents? * How satisfactory are two types of mindful self-compassion programs for adolescents? To do this, the investigators will compare adolescents who complete two types of mindful self-compassion programs to adolescents in a "waitlist control" condition (who complete no study tasks during the program period, but will have the opportunity to complete the program at the end of the study). Participants will: * Complete a brief phone interview to confirm their eligibility (15 min) * Complete an online survey including questions about coping, mental health, and academic engagement (30 min) * Complete a live, online, four-week-long mindful self-compassion program OR no study tasks during this four-week period (if randomly assigned to a waitlist condition) * Complete an online survey 1 week after the 4-week period, including questions about coping, mental health, and academic engagement, as well as their liking of the program they completed (if applicable) * Complete an online survey 1 month after the 4-week period, including questions about coping, mental health, and academic engagement * (Waitlist condition only) Have the opportunity to complete one of the two mindful self-compassion programs after the study had ended
Eligibility Criteria
Inclusion Criteria: * Be 14-19 years of age for the duration of the study; * If 14-17 years of age: have a parent with sufficient literacy skills to understand the consent process and have the ability to provide written informed consent, and have sufficient English fluency and literacy skills themselves to understand the assent process, procedures, and questionnaires and have the ability to provide written assent; * If 18-19 years of age: have sufficient English fluency and literacy skills themselves to understand the consent process, procedures, and questionnaires and have the ability to provide written informed consent; * Have access to the internet and an electronic device with adequate data capacity to complete questionnaires online and attend online videoconference groups; * Be available and willing to attend the scheduled online videoconference groups for 4 weeks and complete the online assessments. Exclusion Criteria: * Current or past-year treatment with mindfulness-based psychotherapy (e.g., MBCT, DBT, or ACT); * Current or past-year participation in a mindfulness- or compassion-based program; * A routine of, on average, 10 minutes of mindfulness practice per day over the past 30 days (greater than or equal to 300 minutes); * Simultaneous participation in another experimental research study; * Current or past-year diagnosis of: schizophrenia spectrum or other psychotic disorder, bipolar 1 disorder, or severe substance/alcohol use disorder; * Current or past-month suicidal ideation; * Hospitalization for reasons related to mental health within the past 6 months; * Recent modifications to psychiatric medication(s) (within the last 30 days or within the last 90 days for antidepressants (e.g., SSRI, SNRI, etc.); * Inability to complete consent/assent process or baseline assessment.
Contact & Investigator
Zev Schuman-Olivier, MD
PRINCIPAL INVESTIGATOR
Cambridge Health Alliance
Frequently Asked Questions
Who can join the NCT07513220 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 19 Years, studying Coping. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07513220 currently recruiting?
Yes, NCT07513220 is actively recruiting participants. Contact the research team at mscteen@challiance.org for enrollment information.
Where is the NCT07513220 trial being conducted?
This trial is being conducted at Malden, United States.
Who is sponsoring the NCT07513220 clinical trial?
NCT07513220 is sponsored by Cambridge Health Alliance. The principal investigator is Zev Schuman-Olivier, MD at Cambridge Health Alliance. The trial plans to enroll 135 participants.